ADMA BIOLOGICS, INC. Deposits Assets, Noncurrent
ADMA BIOLOGICS, INC. (ADMA) had Deposits Assets, Noncurrent of $2.22 million as of 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DepositsAssetsNoncurrent · last filed 2021-05-12
- 2021-03-31: Deposits Assets, Noncurrent $2.22M.
- 2020-12-31: Deposits Assets, Noncurrent $2.11M.
- 2020-09-30: Deposits Assets, Noncurrent $1.87M.
- 2020-06-30: Deposits Assets, Noncurrent $4.85M.
| Period end | Deposits Assets, Noncurrent | Deposits Assets, Noncurrent as first filed |
|---|---|---|
| 2021-03-31 | $2.22M 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $2.11M 10-Q · filed 2021-05-12 | |
| 2020-09-30 | $1.87M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $4.85M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $3.47M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $1.60M 10-K · filed 2021-03-25 | $2.84M 10-K · filed 2020-03-13 |
| 2019-09-30 | $2.84M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $2.83M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $2.77M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $1.54M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $530.17K 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $533.42K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $539.57K 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $1.34M 10-K · filed 2019-03-13 | $510.06K 10-K · filed 2018-03-29 |
| 2017-09-30 | $750.69K 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $502.45K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $29.56K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $27.16K 10-K · filed 2018-03-29 | |
| 2016-09-30 | $27.16K 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $27.16K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $27.16K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $27.16K 10-K · filed 2017-02-24 | |
| 2015-09-30 | $27.16K 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $27.16K 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $27.16K 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $27.16K 10-K · filed 2016-03-23 | |
| 2014-09-30 | $27.16K 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $27.16K 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $27.16K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $12.58K 10-K · filed 2015-03-09 | |
| 2013-09-30 | $12.58K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $12.58K 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $12.58K 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $12.58K 10-K · filed 2014-03-28 | |
| 2012-09-30 | $12.58K 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $12.58K 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $12.58K 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $12.58K 10-K · filed 2013-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |